NCT05095467View on ClinicalTrials.gov

HIPEC-AS in Patients With Peritoneal Metastasis of the Stomach or Esophagogastric Junction

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

October 31, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2026

Conditions
Stomach NeoplasmsPeritoneal Metastases
Interventions
PROCEDURE

HIPEC

The abdominal cavity will be filled with paclitaxel 120mg/m2 heated at 43℃ for 1 hour with a hyperthermic circulation machine.

DRUG

Paclitaxel-albumin

albumin paclitaxel D1, D8; S-1: D1-D14

DRUG

Tegafur-gimeracil-oteracil potassium

40mg bid(BSA\<1.5 m2) ，60mg bid(BSA\>=1.5 m2); D1-D14, po, bid.

PROCEDURE

Surgery+HIPEC

gastrectomy with D2 lymphadenectomy+HIPEC procedure

All Listed Sponsors
lead

Xuefei.Wang

OTHER